LLY

1,039.1

-0.58%↓

JNJ

211.17

+0.87%↑

ABBV

225.74

+1.42%↑

UNH

332.56

+0.23%↑

AZN

90.41

-0.41%↓

LLY

1,039.1

-0.58%↓

JNJ

211.17

+0.87%↑

ABBV

225.74

+1.42%↑

UNH

332.56

+0.23%↑

AZN

90.41

-0.41%↓

LLY

1,039.1

-0.58%↓

JNJ

211.17

+0.87%↑

ABBV

225.74

+1.42%↑

UNH

332.56

+0.23%↑

AZN

90.41

-0.41%↓

LLY

1,039.1

-0.58%↓

JNJ

211.17

+0.87%↑

ABBV

225.74

+1.42%↑

UNH

332.56

+0.23%↑

AZN

90.41

-0.41%↓

LLY

1,039.1

-0.58%↓

JNJ

211.17

+0.87%↑

ABBV

225.74

+1.42%↑

UNH

332.56

+0.23%↑

AZN

90.41

-0.41%↓

Search

Twist Bioscience Corp

Open

SectorHealthcare

32.28 6.53

Overview

Share price change

24h

Current

Min

30.39

Max

33.31

Key metrics

By Trading Economics

Income

-48M

-27M

Sales

3M

99M

EPS

-0.45

Profit margin

-27.41

Employees

979

EBITDA

3.2M

-21M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+23.91% upside

Market Stats

By TradingEconomics

Market Cap

101M

2B

Previous open

25.75

Previous close

32.28

News Sentiment

By Acuity

50%

50%

169 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Twist Bioscience Corp Chart

Past performance is not a reliable indicator of future results.

Related News

16 Dec 2025, 23:46 UTC

Market Talk

Gold Edges Higher, Aided by Fed Rate-Cut Prospects -- Market Talk

16 Dec 2025, 23:38 UTC

Market Talk

Nikkei May Rise on Possible Bargain-Hunting Interest -- Market Talk

16 Dec 2025, 22:35 UTC

Acquisitions, Mergers, Takeovers

Santos: Sale Delivered Cash, Reduced Future Decommissioning Exposure

16 Dec 2025, 22:35 UTC

Acquisitions, Mergers, Takeovers

Santos Sold 43% Stake in Petrel Fields, 100% of Tern Fields to Eni Australia

16 Dec 2025, 22:33 UTC

Acquisitions, Mergers, Takeovers

Santos: A$40M Upfront Consideration, Up to A$20M in Contingent Payments

16 Dec 2025, 22:33 UTC

Acquisitions, Mergers, Takeovers

Santos Sold 43% Operated Interest in Mahalo JV to Comet Ridge

16 Dec 2025, 22:32 UTC

Acquisitions, Mergers, Takeovers

Santos Divests Two Noncore Assets as Part of Portfolio Optimization

16 Dec 2025, 22:25 UTC

Acquisitions, Mergers, Takeovers

Westgold's Indicative Timetable Points to Early February Completion

16 Dec 2025, 22:24 UTC

Acquisitions, Mergers, Takeovers

Westgold: Divestment Aligns With Broader Corporate Strategy

16 Dec 2025, 22:23 UTC

Acquisitions, Mergers, Takeovers

Westgold: Deferred Payment Based on Performance Hurdles

16 Dec 2025, 22:23 UTC

Acquisitions, Mergers, Takeovers

Westgold Will Receive A$15M Cash, A$19.6M in Alicanto Shares

16 Dec 2025, 22:23 UTC

Acquisitions, Mergers, Takeovers

Westgold to Receive A$30M Deferred Payment in Cash or Shares

16 Dec 2025, 22:22 UTC

Acquisitions, Mergers, Takeovers

Westgold Divesting Noncore Operating Asset for A$64.6M

16 Dec 2025, 22:22 UTC

Acquisitions, Mergers, Takeovers

Westgold Agrees to Sell Mt Henry-Selene Project to Alicanto Minerals

16 Dec 2025, 21:53 UTC

Earnings

Lennar Misses Earnings Estimates. The Stock Is Dropping. -- Barrons.com

16 Dec 2025, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

16 Dec 2025, 21:33 UTC

Acquisitions, Mergers, Takeovers

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- 2nd Update

16 Dec 2025, 21:18 UTC

Acquisitions, Mergers, Takeovers

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- Update

16 Dec 2025, 21:17 UTC

Acquisitions, Mergers, Takeovers

Worthington Enterprises to Buy LSI Group for About $205M >WOR

16 Dec 2025, 21:16 UTC

Earnings

Worthington Enterprises 2Q Sales $327.5M >WOR

16 Dec 2025, 21:16 UTC

Earnings

Worthington Enterprises 2Q Adj EPS 65c >WOR

16 Dec 2025, 21:16 UTC

Earnings

Worthington Enterprises 2Q EPS 55c >WOR

16 Dec 2025, 21:15 UTC

Acquisitions, Mergers, Takeovers

Worthington Enterprises Agrees To Acquire Leading Metal Roof Components Manufacturer LSI Group >WOR

16 Dec 2025, 21:05 UTC

Acquisitions, Mergers, Takeovers

Ecolab Closes Acquisition Of Ovivo's Electronics Ultrapure Water Business >ECL

16 Dec 2025, 20:54 UTC

Acquisitions, Mergers, Takeovers

Warner to Reject Paramount Offer As Soon As Wednesday, Sources Say -- WSJ

16 Dec 2025, 20:54 UTC

Acquisitions, Mergers, Takeovers

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- WSJ

16 Dec 2025, 20:54 UTC

Acquisitions, Mergers, Takeovers

Warner to Recommend Existing Netflix Deal, Sources Say -- WSJ

16 Dec 2025, 20:44 UTC

Market Talk

Russia-Ukraine Peace Efforts Send Crude to Near 5-Year Low -- Market Talk

16 Dec 2025, 20:04 UTC

Market Talk

U.S. Natural Gas Extends Weather-Driven Losing Streak -- Market Talk

16 Dec 2025, 20:01 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Peer Comparison

Price change

Twist Bioscience Corp Forecast

Price Target

By TipRanks

23.91% upside

12 Months Forecast

Average 38.5 USD  23.91%

High 42 USD

Low 32 USD

Based on 5 Wall Street analysts offering 12 month price targets forTwist Bioscience Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

31.56 / 38.6884Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

169 / 374 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Twist Bioscience Corp

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, it offers synthetic SARS-CoV-2 RNA reference sequences as positive controls to develop both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company has a strategic collaboration with bitBiome Inc. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
help-icon Live chat